Showing results (261-270 of 334) with videos related to

Sort By:
Pageof 34
Vaccine|May 21, 2026
Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC studyBrigitte Ranque, Florence Galtier, Hilario Nunes, et al.
Blood|July 18, 2012
Pivotal role of M-DC8⁺ monocytes from viremic HIV-infected patients in TNFα overproduction in response to microbial productsCharles-Antoine Dutertre, Sonia Amraoui, Annalisa DeRosa, et al.
Plos One|August 23, 2007
Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trialOdile Launay, Christine Durier, Corinne Desaint, et al.
Ebiomedicine|July 25, 2017
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in EuropeOdile Launay, David J M Lewis, Alessandra Anemona, et al.
Expert Review of Vaccines|October 20, 2022
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiativeJavier Díez-Domingo, Laurence Torcel-Pagnon, Antonio Carmona, et al.
Eclinicalmedicine|December 9, 2024
Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)Yves Levy, Christiane Moog, Aurélie Wiedemann, et al.
Infection|February 15, 2020
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter studyFrançois Bénézit, Paul Loubet, Florence Galtier, et al.
The Journal of Infectious Diseases|July 16, 2025
Characteristics of Human Metapneumovirus Infection Compared to Respiratory Syncytial Virus and Influenza Infections in Adults Hospitalized for Influenza-Like Illness in France, 2012-2022Paul Loubet, Salomé Guitton, Simon Rolland, et al.
NPJ Vaccines|June 25, 2019
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trialVincent Vieillard, Béhazine Combadière, Roland Tubiana, et al.
BMC Infectious Diseases|February 3, 2016
Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemyJulie Bucher, Pierre-Yves Boelle, Dominique Hubert, et al.
Pageof 34